<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus (EBV)-specified DNA polymerase was purified from P3HR-1 cells, a Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> EBV producer cell line, treated with <z:chebi fb="0" ids="17598">phorbol-12,13-dibutyrate</z:chebi> (PDB) and <z:chebi fb="0" ids="17968">n-butyrate</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Its inhibition by aphidicolin, phosphonoformate (<z:chebi fb="95" ids="53371">PFA</z:chebi>) and <z:chebi fb="0" ids="17345">5'-GMP</z:chebi> was examined </plain></SENT>
<SENT sid="2" pm="."><plain>Aphidicolin could inhibit EBV DNA polymerase competitively with respect to <z:chebi fb="0" ids="16284">dATP</z:chebi> and <z:chebi fb="0" ids="16311">dCTP</z:chebi> and noncompetitively with respect to <z:chebi fb="0" ids="16497">dGTP</z:chebi> and <z:chebi fb="0" ids="18077">dTTP</z:chebi>; whereas <z:chebi fb="0" ids="17345">5'-GMP</z:chebi> was a noncompetitive inhibitor with respect to <z:hpo ids='HP_0000001'>all</z:hpo> four dNTPs </plain></SENT>
<SENT sid="3" pm="."><plain>Combinations of aphidicolin and <z:chebi fb="95" ids="53371">PFA</z:chebi>, or <z:chebi fb="95" ids="53371">PFA</z:chebi> and <z:chebi fb="0" ids="17345">5'-GMP</z:chebi>, produced a mutually exclusive inhibition pattern of EBV DNA polymerase that suggested that the binding sites of these compounds on the enzyme molecule are kinetically overlapping </plain></SENT>
</text></document>